Evidence map›Paper›PMID 28164379›Full record

ArticleMolecular microbiology2017

Peptide-nucleotide antibiotic Microcin C is a potent inducer of stringent response and persistence in both sensitive and producing cells.

Julia Piskunova, Etienne Maisonneuve, Elsa Germain, Kenn Gerdes, Konstantin Severinov

Open access · bronzeAbstract read
In one paragraph

Article in Molecular microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Microcins inFrontiers in microbiology · 2019
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 3 countries.

Julia PiskunovaSkolkovo Institute of Science and Technology, Skolkovo, 143025, Russia.
Etienne MaisonneuveDepartment of Biology, University of Copenhagen, Copenhagen, DK-2200, Denmark.
Elsa GermainDepartment of Biology, University of Copenhagen, Copenhagen, DK-2200, Denmark.
Kenn GerdesDepartment of Biology, University of Copenhagen, Copenhagen, DK-2200, Denmark.ORCID http://orcid.org/0000-0002-7462-4612
Konstantin SeverinovSkolkovo Institute of Science and Technology, Skolkovo, 143025, Russia.ORCID http://orcid.org/0000-0001-9706-450X
University of Copenhagen · DKRutgers, The State University of New Jersey · US

Funding

Exploring Peptide Conjugates as Trojan Horse Systems for Drug Design and DiscoveryR01AI117210 · NIAID · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI NAIR, SATISH K · 2016 to 2020
$2.2M
NIAID NIH HHS R01 AI117210
6 · The paper itself

Abstract

Microcin C (McC) is a peptide-nucleotide antibiotic that inhibits aspartyl-tRNA synthetase. Here, we show that McC is a strong inducer of persistence in Escherichia coli. Persistence induced by McC is mediated by (p)ppGpp and requires chromosomally encoded toxin-antitoxin modules. McC-producing cells have increased persistence levels due to a combined effect of McC imported from the cultured medium and intracellularly synthesized antibiotic. McC-producing cells also induce persistence in sensitive cells during co-cultivation, underscoring complex interactions in bacterial communities where an antagonistic compound produced by one community member can benefit other members by increasing their ability to withstand antibiotics.

Indexed as

Anti-Bacterial AgentsAspartate-tRNA LigaseBacteriocinsEscherichia coliEscherichia coli ProteinsGene Expression Regulation, BacterialPhosphorylationAnti-Bacterial AgentsAspartate-tRNA LigaseBacteriocinsEscherichia coli Proteinsmicrocin

Identifiers

PMID28164379
PMCPMC6876116
OpenAlexW2587077973

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.